论文信息 - Final Results from a Phase II Study Combining Azacitidine and Pembrolizumab in Patients with Higher-Risk Myelodysplastic Syndrome after Failure of Hypomethylating Agent Therapy - 字舞流文

Final Results from a Phase II Study Combining Azacitidine and Pembrolizumab in Patients with Higher-Risk Myelodysplastic Syndrome after Failure of Hypomethylating Agent Therapy

M. Andreeff | H. Kantarjian | G. Garcia-Manero | J. Cortes | G. Borthakur | E. Jabbour | N. Daver | C. Dinardo | S. Pierce | N. Jain | Y. Alvarado | K. Soltysiak | P. Bose | K. Naqvi | K. Chien | G. Bravo | Kimberly B. Sheppard | C. Klingner-Winton | X. Dong